Cannabis Use and its Association with Psychological Disorders.
Urits I, Gress K, Charipova K, Li N, Berger AA, Cornett EM, Hasoon J, Kassem H, Kaye AD, Viswanath O.
Psychopharmacol Bull. 2020 May 19;50(2):56-67.
Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016.
Tomás CC, Oliveira E, Sousa D, Uba-Chupel M, Furtado G, Rocha C, Teixeira A, Ferreira P, Alves C, Gisin S, Catarino E, Carvalho N, Coucelo T, Bonfim L, Silva C, Franco D, González JA, Jardim HG, Silva R, Baixinho CL, Presado MªH, Marques MªF, Cardoso ME, Cunha M, Mendes J, Xavier A, Galhardo A, Couto M, Frade JG, Nunes C, Mesquita JR, Nascimento MS, Gonçalves G, Castro C, Mártires A, Monteiro MªJ, Rainho C, Caballero FP, Monago FM, Guerrero JT, Monago RM, Trigo AP, Gutierrez ML, Milanés GM, Reina MG, Villanueva AG, Piñero AS, Aliseda IR, Ramirez FB, Ribeiro A, Quelhas A, Manso C, Caballero FP, Guerrero JT, Monago FM, Santos RB, Jimenez NR, Nuñez CG, Gomez IR, Fernandez MªJL, Marquez LA, Moreno AL, Huertas MªJT, Ramirez FB, Seabra D, Salvador MªC, Braga L, Parreira P, Salgueiro-Oliveira A, Arreguy-Sena C, Oliveira BF, Henriques MªA, Santos J, Lebre S, Marques A, Festas C, Rodrigues S, Ribeiro A, Lumini J, Figueiredo AG, Hernandez-Martinez FJ, Campi L, Quintana-Montesdeoca MªP, Jimenez-Diaz JF, Rodriguez-De-Vera BC, Parente A, Mata MªA, Pereira AMª, Fernandes A, Brás M, Pinto MªR, Parreira P, Basto ML, Rei AC, Mónico LM, Sousa G, Morna C, Freitas O, Freitas G, Jardim A, Vasconcelos …
BMC Health Serv Res. 2016 Jul 6;16 Suppl 3(Suppl 3):200. doi: 10.1186/s12913-016-1423-5.
Role of cannabinoids in alcohol-induced neuroinflammation.
García-Baos A, Alegre-Zurano L, Cantacorps L, Martín-Sánchez A, Valverde O.
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110054. doi: 10.1016/j.pnpbp.2020.110054. Epub 2020 Aug 3.
Psychoactive substances for the treatment of neuropsychiatric disorders.
Zhen Z, Sun X, Yuan S, Zhang J.
Asian J Psychiatr. 2024 Nov;101:104193. doi: 10.1016/j.ajp.2024.104193. Epub 2024 Sep 3.
Responding to illicit drug use in family practice.
Robertson JR, Robertson AR.
Curr Opin Psychiatry. 2015 Jul;28(4):286-91. doi: 10.1097/YCO.0000000000000174.
Alcohol and other drug use among Belgian workers and job-related consequences.
Lambrechts MC, Vandersmissen L, Godderis L.
Occup Environ Med. 2019 Sep;76(9):652-659. doi: 10.1136/oemed-2019-105690.
Determinants of mental health and abuse of psychoactive substances associated with tobacco use. A case-control study.
Amorim TA, Lucchese R, Silva Neta EMD, Santos JSD, Vera I, Paula NI, Simões ND, Monteiro LHB.
Cien Saude Colet. 2019 Oct 28;24(11):4141-4152. doi: 10.1590/1413-812320182411.02752018. eCollection 2019.
Delphi method applicability in drug foresight.
Lintonen T, Karjalainen K, Rönkä S, Kotovirta E, Niemelä S.
Subst Abuse Treat Prev Policy. 2024 Jul 27;19(1):35. doi: 10.1186/s13011-024-00617-7.
Crisis intervention related to the use of psychoactive substances in recreational settings--evaluating the Kosmicare Project at Boom Festival.
Carvalho MC, de Sousa MP, Frango P, Dias P, Carvalho J, Rodrigues M, Rodrigues T.
Curr Drug Abuse Rev. 2014;7(2):81-100. doi: 10.2174/1874473708666150107115515.
Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence.
Busto UE, Romach MK, Sellers EM.
J Clin Psychopharmacol. 1996 Feb;16(1):51-7. doi: 10.1097/00004714-199602000-00009.
